GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

She was diagnosed with a genetic kidney disease called reflux nephropathy which later progressed to kidney failure. "That was ...

A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

Mefenamic acid, a common anti-inflammatory drug already approved for pain management, has been found to significantly reduce ...

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, published in Science, from researchers at the Perelman School of Medicine at the ...

Despite an increase in the use of medication for opioid use disorder in older adults from 2017 to 2022, disparities persist; ...